Nov 18, 2015
Chemotherapy in AML
Chemotherapy in AML
Larry H. Bernstein, MD, FCAP, Curator
LPBI
Sorafenib Showed Efficacy as Chemotherapy Add-On in AML Results from the phase II SORAML trial indicated that adding sorafenib to standard chemotherapy for younger patients with acute myeloid leukemia was effective, but also resulted in increased toxicity
Reduced-Intensity HSCT Extends Remission in Older AML Patients The use of…
View On WordPress